Why the study?
Does drug-coated balloon angioplasty reduce target lesion failure risk in patients with de novo lesions on the left anterior descending artery?
Does drug-coated balloon angioplasty reduce target lesion failure risk in patients with de novo lesions on the left anterior descending artery?
Drug-coated balloon angioplasty for de novo LAD lesions reduces stent burden and may lower midterm target lesion failure risk.
Answers are grounded in this paper and cite their sources.
May support DCB strategies to reduce stent burden in de novo LAD lesions; leaves open impact on target lesion failure pending randomized data.
A DCB-based treatment approach for left anterior descending revascularization allows a significantly reduced stent burden, thereby potentially limiting target lesion failure risk at midterm follow-up.
No takes yet. Share an insight, caveat, or question.
Gitto et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: